Commentary

Podcast

Pharmacy Focus: Oncology Edition- Pharmacists Pivotal Role in Driving Clinical Trial Research

Pharmacists from Mayo Clinic recap some of the latest treatment opportunities to advance patient care in the oncology space.

This episode recaps some of the latest treatment opportunities to advance patient care in the oncology space, shared by oncology pharmacists from Mayo Clinic. We start by speaking with Jodi Taraba, PharmD, MS, BCOP, a breast cancer clinical pharmacist at Mayo Clinic. She offers insights into the pivotal role of pharmacists in driving clinical trial research. Next, we spoke with Candy Pesky, PharmD, BCPS, BCOP, a cancer center care team pharmacist with Mayo Clinic in Rochester, Minnesota. She shares insights into how pharmacists can facilitate patient access to enrollment in clinical trials, Lastly, we spoke with Scott Soefje, PharmD, BCOP, FCCP, FHOPA, MBA, director of pharmacy cancer care at Mayo Clinic. He discusses the pivotal role of oncology pharmacists.

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
Image Credit: © Krakenimages.com - stock.adobe.com